IPF
Showing 51 - 75 of 558
Idiopathic Pulmonary Fibrosis Trial in Canada (60% Oxygen, Standard of Care)
Recruiting
- Idiopathic Pulmonary Fibrosis
- 60% Oxygen
- Standard of Care
-
Calgary, Alberta, Canada
- +7 more
May 17, 2022
Idiopathic Pulmonary Fibrosis Trial in Durham (Hyperpolarized 129 Xenon Gas Comparing Idiopathic Pulmonary Fibrosis (IPF)
Recruiting
- Idiopathic Pulmonary Fibrosis
- Hyperpolarized 129 Xenon Gas Comparing Idiopathic Pulmonary Fibrosis (IPF) Treatment
-
Durham, North CarolinaDuke University Medical Center
May 3, 2022
Nalbuphine, Idiopathic Pulmonary Fibrosis, Cough Trial in United Kingdom (Nalbuphine ER, Placebo oral tablet)
Completed
- Nalbuphine
- +2 more
- Nalbuphine ER
- Placebo oral tablet
-
Antrim, Northern Ireland, United Kingdom
- +14 more
Oct 3, 2022
Idiopathic Pulmonary Fibrosis Trial (CHF10067 starting dose, CHF10067 intermediate dose, CHF10067 high dose)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- CHF10067 starting dose
- +3 more
- (no location specified)
Aug 22, 2022
Patients With IPF
Completed
- Idiopathic Pulmonary Fibrosis
-
Aarhus, DenmarkAarhus University Hospital, Department of Respiratory Diseases a
Aug 9, 2021
Genetics of IPF - Screening Study for Family Members
Recruiting
- Idiopathic Pulmonary Fibrosis (IPF)
- High Resolution CT scan of the chest
- +2 more
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Sep 29, 2021
Idiopathic Pulmonary Fibrosis Trial in Beijing (HEC585, Pirfenidone, Placebo)
Recruiting
- Idiopathic Pulmonary Fibrosis
- HEC585
- +2 more
-
Beijing, Beijing, ChinaChina-Japan Friendship Hospital
Sep 18, 2021
Idiopathic Pulmonary Fibrosis Trial in Beijing (AK3280, Placebo)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- AK3280
- Placebo
-
Beijing, Beijing, ChinaChina-Japan Friendship Hospital
Jul 19, 2022
Idiopathic Pulmonary Fibrosis Trial in Charleston (DWN12088, Placebo)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- DWN12088
- Placebo
-
Charleston, South CarolinaDaewoong Investigator site
Jul 25, 2022
stratification for IPF and COPD
Not yet recruiting
- Lung; Disease, Interstitial, With Fibrosis
- +2 more
- Lung auscultation
- +3 more
-
Sion, Wallis, SwitzerlandCentre Hospitalier du Valais Romand
Sep 1, 2022
Idiopathic Pulmonary Fibrosis Trial in United States
Active, not recruiting
- Idiopathic Pulmonary Fibrosis
-
Baltimore, Maryland
- +4 more
Oct 29, 2021
IPF Trial in Istanbul (Telerehabilitation exercise program, Videobased exercise program)
Recruiting
- IPF
- Telerehabilitation exercise program
- Videobased exercise program
-
Istanbul, Zeytinburnu, TurkeyYedikule Chest Disease Hospital
Jan 22, 2022
Idiopathic Pulmonary Fibrosis (IPF) Trial (ANG-3070, Placebo)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis (IPF)
- ANG-3070
- Placebo
- (no location specified)
Jun 8, 2022
Advancing Prevention of Pulmonary Fibrosis
Recruiting
- IPF
- +2 more
- Sample collection
- +3 more
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Aug 18, 2022
Cohort of IPF Patients Experiencing an Exacerbation
Recruiting
- Idiopathic Pulmonary Fibrosis
-
Hellerup, Copenhagen, DenmarkHerlev and Gentofte Hospital
Oct 26, 2021
Sleep Hygiene, Sarcopenia, and Cognitive Function in Respiratory
Recruiting
- Sleep Hygiene
- +4 more
-
Joyo, Kyoto, JapanNational Hospital Organization Minami Kyoto Hospital
Jan 13, 2022
Idiopathic Pulmonary Fibrosis Trial in Hospitalet de Llobregat (Comprehensive patient support program (educational,
Completed
- Idiopathic Pulmonary Fibrosis
- Comprehensive patient support program (educational, physiotherapy, nutritional, emotional)
-
Hospitalet de Llobregat, SpainIDIBELL. University Hospital of Bellvitge
Dec 12, 2021
Idiopathic Pulmonary Fibrosis Trial in United States (N-acetyl cysteine, Placebo)
Recruiting
- Idiopathic Pulmonary Fibrosis
- N-acetyl cysteine
- Placebo
-
Tucson, Arizona
- +24 more
Jan 14, 2023
Idiopathic Pulmonary Fibrosis Trial in Kingston (Nitric Oxide, Medical air)
Recruiting
- Idiopathic Pulmonary Fibrosis
- Nitric Oxide
- Medical air
-
Kingston, Ontario, CanadaRespiratory Investigation Unit, Kingston General Hospital
Apr 21, 2022
Healthy Participants, Idiopathic Pulmonary Fibrosis (IPF) Trial in New Haven (18F-BMS-986327)
Recruiting
- Healthy Participants
- Idiopathic Pulmonary Fibrosis (IPF)
- 18F-BMS-986327
-
New Haven, ConnecticutYale Positron Emission Tomography Center
Mar 30, 2022
Idiopathic Pulmonary Fibrosis Trial in Sunnyvale (No intervention)
Recruiting
- Idiopathic Pulmonary Fibrosis
- No intervention
-
Sunnyvale, California23andMe
Sep 9, 2021
Idiopathic Pulmonary Fibrosis (IPF) Trial in Aurora (N-acetyl cysteine then Placebo, Placebo then N-acetyl cysteine)
Withdrawn
- Idiopathic Pulmonary Fibrosis (IPF)
- N-acetyl cysteine then Placebo
- Placebo then N-acetyl cysteine
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Jun 3, 2021
Idiopathic Pulmonary Fibrosis (IPF) Trial (XFB-19, Placebo)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis (IPF)
- XFB-19
- Placebo
- (no location specified)
Jul 14, 2022
Turkish Validity and Reliability of SGRQ-I
Recruiting
- IPF
- Questionnaire
-
İstanbul, Üsküdar, TurkeyEsra Pehlivan
Jan 9, 2022